Financing Comprehensive Immunization Services in Lao PDR: A Fiscal Space Analysis From a Public Policy Perspective
Pankaj Bahuguna,
Emiko Masaki,
Gursimer Jeet and
Shankar Prinja ()
Additional contact information
Pankaj Bahuguna: Post Graduate Institute of Medical Education and Research
Emiko Masaki: World Bank
Gursimer Jeet: Post Graduate Institute of Medical Education and Research
Shankar Prinja: Post Graduate Institute of Medical Education and Research
Applied Health Economics and Health Policy, 2023, vol. 21, issue 1, No 12, 140 pages
Abstract:
Abstract Introduction A comprehensive package of immunization services is an internal component of the Essential Health Service Package (ESP) implemented by Government of Lao People’s Democratic Republic (Lao PDR). Thus, the cost of delivering the immunization program and its feasibility given the fiscal space emerges as an important policy question. The present analysis was undertaken to estimate the total cost of implementing the immunization program under ESP, determinants of total cost and the program’s fiscal implications from the government’s perspective. Methodology We employed a normative costing approach for costing of immunization services under ESP. Standard treatment guidelines (STGs) from both within and outside Lao PDR were considered to identify the resource use for each vaccine delivery. Subsequently, cost per dose administered and fully immunized beneficiary were computed. We assessed the fiscal space for financing immunization services in Lao PDR by adapting the decomposition method given by Tandon et al. Results In 2019, the estimated total cost of financing immunization in Lao PDR was US$12 million, which will increase in 2025 by 1.75 times, to US$21 million. The per capita budget for immunization needs to increase from about US$2 to US$7. Introduction of newer vaccines in the immunization schedule accounts for the major share (60%) of the increased cost for financing immunization. In view of current fiscal space, the government immunization expenditure (GIE) allocations will be adequate only in a scenario where no new vaccine is introduced under ESP in future years. Conclusion The current fiscal space would fall short of meeting the aspirational goals of ESP–Immunization for the introduction of newer vaccines in Lao PDR. The present analysis of the fiscal space provides important evidence to support a greater role for the Global Alliance for Vaccine Initiative (GAVI) to continue to finance immunization in Lao PDR. A publicly financed immunization model in Lao PDR would require significant strategic amendments with low short-term viability.
Date: 2023
References: View references in EconPapers View complete reference list from CitEc
Citations:
Downloads: (external link)
http://link.springer.com/10.1007/s40258-022-00763-8 Abstract (text/html)
Access to the full text of the articles in this series is restricted.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:spr:aphecp:v:21:y:2023:i:1:d:10.1007_s40258-022-00763-8
Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/40258
DOI: 10.1007/s40258-022-00763-8
Access Statistics for this article
Applied Health Economics and Health Policy is currently edited by Timothy Wrightson
More articles in Applied Health Economics and Health Policy from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().